My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 121

    1.

    Glucose increases endothelial-dependent superoxide formation in coronary arteries by NAD(P)H oxidase activation: attenuation by the 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor atorvastatin.

    Christ M, Bauersachs J, Liebetrau C, Heck M, Günther A, Wehling M.

    Diabetes. 2002 Aug;51(8):2648-52.PMID: 12145183 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Improvement of nitric oxide-dependent vasodilatation by HMG-CoA reductase inhibitors through attenuation of endothelial superoxide anion formation.

    Wagner AH, Köhler T, Rückschloss U, Just I, Hecker M.

    Arterioscler Thromb Vasc Biol. 2000 Jan;20(1):61-9.PMID: 10634801 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Withdrawal of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors elicits oxidative stress and induces endothelial dysfunction in mice.

    Vecchione C, Brandes RP.

    Circ Res. 2002 Jul 26;91(2):173-9.PMID: 12142351 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Cellular antioxidant effects of atorvastatin in vitro and in vivo.

    Wassmann S, Laufs U, Müller K, Konkol C, Ahlbory K, Bäumer AT, Linz W, Böhm M, Nickenig G.

    Arterioscler Thromb Vasc Biol. 2002 Feb 1;22(2):300-5.PMID: 11834532 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    3-hydroxy-3-methylglutaryl coenzyme A reductase-independent inhibition of CD40 expression by atorvastatin in human endothelial cells.

    Wagner AH, Gebauer M, Güldenzoph B, Hecker M.

    Arterioscler Thromb Vasc Biol. 2002 Nov 1;22(11):1784-9.PMID: 12426205 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    HMG-CoA reductase inhibitors improve endothelial dysfunction in normocholesterolemic hypertension via reduced production of reactive oxygen species.

    Wassmann S, Laufs U, Bäumer AT, Müller K, Ahlbory K, Linz W, Itter G, Rösen R, Böhm M, Nickenig G.

    Hypertension. 2001 Jun;37(6):1450-7.PMID: 11408394 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Induction of NAD(P)H oxidase by oxidized low-density lipoprotein in human endothelial cells: antioxidative potential of hydroxymethylglutaryl coenzyme A reductase inhibitor therapy.

    Rueckschloss U, Galle J, Holtz J, Zerkowski HR, Morawietz H.

    Circulation. 2001 Oct 9;104(15):1767-72.PMID: 11591612 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Mechanisms underlying recoupling of eNOS by HMG-CoA reductase inhibition in a rat model of streptozotocin-induced diabetes mellitus.

    Wenzel P, Daiber A, Oelze M, Brandt M, Closs E, Xu J, Thum T, Bauersachs J, Ertl G, Zou MH, Förstermann U, Münzel T.

    Atherosclerosis. 2008 May;198(1):65-76. Epub 2007 Dec 3.PMID: 18061195 [PubMed - indexed for MEDLINE]Related articles

    9.

    Nitric oxide synthase and NAD(P)H oxidase modulate coronary endothelial cell growth.

    Bayraktutan U.

    J Mol Cell Cardiol. 2004 Feb;36(2):277-86.PMID: 14871555 [PubMed - indexed for MEDLINE]Related articles

    10.

    NO-mediated regulation of NAD(P)H oxidase by laminar shear stress in human endothelial cells.

    Duerrschmidt N, Stielow C, Muller G, Pagano PJ, Morawietz H.

    J Physiol. 2006 Oct 15;576(Pt 2):557-67. Epub 2006 Jul 27.PMID: 16873416 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Statin-induced expression of decay-accelerating factor protects vascular endothelium against complement-mediated injury.

    Mason JC, Ahmed Z, Mankoff R, Lidington EA, Ahmad S, Bhatia V, Kinderlerer A, Randi AM, Haskard DO.

    Circ Res. 2002 Oct 18;91(8):696-703.PMID: 12386146 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Dose-dependent regulation of NAD(P)H oxidase expression by angiotensin II in human endothelial cells: protective effect of angiotensin II type 1 receptor blockade in patients with coronary artery disease.

    Rueckschloss U, Quinn MT, Holtz J, Morawietz H.

    Arterioscler Thromb Vasc Biol. 2002 Nov 1;22(11):1845-51.PMID: 12426214 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Differential NADPH- versus NADH-dependent superoxide production by phagocyte-type endothelial cell NADPH oxidase.

    Li JM, Shah AM.

    Cardiovasc Res. 2001 Dec;52(3):477-86.PMID: 11738065 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    NAD(P)H oxidase inhibition improves endothelial function in rat and human blood vessels.

    Hamilton CA, Brosnan MJ, Al-Benna S, Berg G, Dominiczak AF.

    Hypertension. 2002 Nov;40(5):755-62.PMID: 12411473 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Expression of functionally phagocyte-type NAD(P)H oxidase in pericytes: effect of angiotensin II and high glucose.

    Manea A, Raicu M, Simionescu M.

    Biol Cell. 2005 Sep;97(9):723-34.PMID: 15859946 [PubMed - indexed for MEDLINE]Related articles

    16.

    Simvastatin improves diabetes-induced coronary endothelial dysfunction.

    Tawfik HE, El-Remessy AB, Matragoon S, Ma G, Caldwell RB, Caldwell RW.

    J Pharmacol Exp Ther. 2006 Oct;319(1):386-95. Epub 2006 Jul 18.PMID: 16849625 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    High-dose atorvastatin improves hypercholesterolemic coronary endothelial dysfunction without improving the angiogenic response.

    Boodhwani M, Nakai Y, Voisine P, Feng J, Li J, Mieno S, Ramlawi B, Bianchi C, Laham R, Sellke FW.

    Circulation. 2006 Jul 4;114(1 Suppl):I402-8.PMID: 16820608 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    High pressure induces superoxide production in isolated arteries via protein kinase C-dependent activation of NAD(P)H oxidase.

    Ungvari Z, Csiszar A, Huang A, Kaminski PM, Wolin MS, Koller A.

    Circulation. 2003 Sep 9;108(10):1253-8. Epub 2003 Jul 21.PMID: 12874194 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Prednisolone augments superoxide formation in porcine pulmonary artery endothelial cells through differential effects on the expression of nitric oxide synthase and NADPH oxidase.

    Muzaffar S, Shukla N, Angelini GD, Jeremy JY.

    Br J Pharmacol. 2005 Jul;145(5):688-97.PMID: 15852033 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Atorvastatin impairs the myocardial angiogenic response to chronic ischemia in normocholesterolemic swine.

    Boodhwani M, Mieno S, Feng J, Sodha NR, Clements RT, Xu SH, Sellke FW.

    J Thorac Cardiovasc Surg. 2008 Jan;135(1):117-22.PMID: 18179927 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity